HPβCD’s Promise in Treating Ischemic Stroke
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. 2-hydroxypropyl-β-cyclodextrin (HPβCD), a
A forum for researchers, students and applicants in the field of cyclodextrin technology
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. 2-hydroxypropyl-β-cyclodextrin (HPβCD), a
The selective removal of trace heteroatomic contaminants from fuel remains a critical challenge for clean combustion and refinery upgrading, particularly
Natural antimicrobial peptides are a promising new class of antibiotics that offer a potential response to the growing challenge of
/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,
The 19th Edition of the International Conference and Expo on Pharmaceutics and Novel Drug Delivery Systems is scheduled to take
Quorum sensing (QS) is the cell-to-cell communication on cell density, which is based on signal molecules, N-acyl-homoserine lactones (AHLs) for
To date very few journals publish video articles in the field of cyclodextrins, despite this type of article being of
The combination of sulfamethoxazole (SMX) and trimetorphan (TMP) produces a synergistic effect by sequentially inhibiting two critical enzymatic steps in
Interestingly fungal quorum sensing signal molecules (QSMs) were found effective against bacterial biofilms hindering the healing of chronic non-healing wounds
The North American Cyclodextrin Consortium (NACC) will host its first virtual meetup on December 11 at 10:00 AM PST (add
A novel polymer, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC) was synthesized to evaluate its potential as an efficient carrier for the encapsulation of
A high-swelling cyclodextrin polymer (His-CDP) is reported that is facilely synthesized without additional design and templates, to achieve high affinity,
Regulation (European Commission) No. 470/2009 lays down Community procedures for the establishment of residue limits of pharmaceutical active substances, excipients